A quarter of a century ago transition state analysis and transition state analogue design promised the prospect of extraordinarily potent enzyme inhibitors. The present overview describes the transition state analysis of a variety of N-ribosyl transferases, the design and synthesis of extremely powerful transition state analogue inhibitors of these nucleoside processing enzymes, and their current therapeutic uses and potentials.
No takes yet. Share an insight, caveat, or question.
Gary B. Evans (2004) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: